Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 05 symbols : Sny save search
Kymera Therapeutics to Share Novel Preclinical Findings Reinforcing the Advantage of IRAK4 Degraders over Kinase Inhibitors as well as First STAT3 Degrader Results in a Preclinical Model of Th17 Inflammation
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -2.72%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
KYMR | $33.97 -1.22% 130K
|
Health Technology
|
| O: -0.73%
H: 0.55%
C: -8.5%
preclinical therapeutics results pre-clinical
Global Asthma and COPD Drugs Market Report to 2030 - Opportunity Analysis and Industry Forecasts
Published: 2022-05-05 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: 0.46%
SNYNF | $92.966 630
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -2.72%
AZNCF | $135.94 770
|
Health Technology
|
| O: -0.86%
H: 1.57%
C: -0.42%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
GSK | $39.935 -1.4% 900K
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
ABT | $109.02 0.12% 1.7M
|
Health Technology
|
| O: -0.73%
H: 0.12%
C: -1.61%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
AZN | $68.39 -0.5% 1.1M
|
Health Technology
|
| O: -1.35%
H: 0.4%
C: -1.2%
report market drug
Asia Breast Cancer Screening Market Report 2021-2027: China Holds Significant Dominance with with Mammogram Screening Leading the Market
Published: 2022-05-05 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: 0.46%
SNYNF | $92.966 630
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -2.72%
GSK | $39.935 -1.4% 900K
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
report china cancer market breast cancer
Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -2.72%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
therapeutics
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.